Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to follow the study rules and have signed a consent form agreeing to take part
- You are between 18 and 80 years old (male or female)
- You have been diagnosed with a type of heart failure caused by blocked arteries (ischemic) or another cause (non-ischemic)
- You have had heart failure symptoms for at least 3 months before joining the study
- Your heart failure symptoms are at least moderate in severity (you experience symptoms during normal activity or even at rest)
- You already have a CRT-D device (a special pacemaker for heart failure) that has not improved your heart function enough — meaning your heart pumping ability has not improved sufficiently and/or your heart has not reduced in size enough after at least 1 year with the device, and the device battery or one of its leads needs replacing
- You are already receiving the best available standard medical treatment for your heart failure
Who may not be able to join:
- You have had heart bypass surgery, a balloon procedure, or a stent placed in a heart artery within the last 3 months
- You have had a heart attack within the last 3 months
- You are currently experiencing an acute coronary syndrome (a sudden, serious heart condition such as an unstable angina or heart attack)
- You are scheduled to have heart bypass surgery, a balloon procedure, or a stent in the near future
- You are on a waiting list for a heart transplant
- You already have a mechanical heart assist device implanted
- You currently have acute inflammation of the heart muscle (acute myocarditis)
- You have a disease where abnormal substances have built up in the heart muscle (confirm with trial site)
- You have a condition where the heart muscle is abnormally thick (hypertrophic cardiomyopathy)
- You have severe problems with your mitral, tricuspid, or aortic heart valves (either severely narrowed or severely leaking)
- You are currently pregnant, breastfeeding, or not using reliable contraception if you are of childbearing age
- You have a physical or mental condition that would prevent you from taking part in the study
- You are unwilling or unable to follow the study procedures
- You have rheumatic heart disease (heart damage caused by rheumatic fever)
- You have a mechanical (artificial) tricuspid heart valve
- You have another serious medical condition that could affect the study results (confirm with trial site)
- You are currently taking part in another study testing an experimental drug or device
- You would not be available for follow-up appointments during the study
- You have severe chronic kidney disease (your kidneys are functioning at a significantly reduced level — confirm with trial site)
- Your life expectancy is 12 months or less
- You are already taking part in another remote heart monitoring programme
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tariel A Atabekov, Ph.D., Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Phone: +79528002625
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause mortality or worsening of heart failure requiring unplanned hospitalization (%)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.